Sun Pharma Advanced Research Co Complete Financial Statements
SPARC • Review detailed financials to uncover trends, confirm thesis & journal trades
3 Years of Data
2025 - 2023
Complete Financial Data Export
Export complete financial statements for Sun Pharma Advanced Research Co (SPARC).
Downloads include all available records across all periods.
For market performance, see the
SPARC stock price today
.
Profitability Ratios
Net Profit Margin
-950.00%
2025 data
EBITDA Margin
-825.00%
2025 data
Operating Margin
-836.00%
2025 data
Return on Assets
-22.62%
2025 data
Balance Sheet Ratios
Current Ratio
0.15
2025 data
Equity Ratio
-64.58%
2025 data
Asset Turnover
0.02
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
-38.5%
Year-over-Year
Net Profit Growth
+29.0%
Year-over-Year
EBITDA Growth
+35.9%
Year-over-Year
Expense Growth
-36.2%
Year-over-Year
Assets Growth
-34.8%
Year-over-Year
Equity Growth
-272.2%
Year-over-Year
Liabilities Growth
-34.8%
Year-over-Year
Operating Cash Flow Growth
+16.1%
Year-over-Year
Investing Cash Flow Growth
-59.7%
Year-over-Year
Financing Cash Flow Growth
+373.8%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8 | 27 | 19 | 13 | 21 | 18 | 15 | 30 | 58 | 34 | 20 |
| Expenses | 74 | 80 | 62 | 116 | 122 | 110 | 89 | 113 | 137 | 126 | 117 |
| EBITDA | -66 | -53 | -43 | -103 | -101 | -92 | -74 | -83 | -79 | -92 | -96 |
| Operating Profit Margin % | -836.00% | -196.00% | -540.00% | -800.00% | -639.00% | -555.00% | -494.00% | -432.00% | -188.00% | -427.00% | -740.00% |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 8 | 5 | 6 | 1 | 1 | 1 | 3 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -76 | -61 | -52 | -107 | -105 | -96 | -79 | -86 | -82 | -95 | -100 |
| Tax | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -76 | -60 | -52 | -107 | -106 | -96 | -80 | -86 | -82 | -95 | -100 |
| Earnings Per Share (₹) | -2.34 | -1.84 | -1.60 | -3.31 | -3.26 | -2.96 | -2.45 | -2.66 | -2.55 | -2.94 | -3.07 |
Related Pages for Sun Pharma Advanced Research Co
Additional stock information and data for SPARC
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 |
|---|---|---|---|
| ASSETS | |||
| Total Assets | 336 | 515 | 830 |
| Current Assets | 26 | 269 | 455 |
| Fixed Assets | 99 | 108 | 106 |
| Capital Work in Progress | 54 | 44 | 27 |
| Investments | 0 | 2 | 291 |
| Other Assets | 183 | 362 | 407 |
| LIABILITIES | |||
| Total Liabilities | 336 | 515 | 830 |
| Current Liabilities | 178 | 124 | 138 |
| Non-Current Liabilities | |||
| SHAREHOLDERS' EQUITY | |||
| Total Equity | -217 | 126 | 513 |
| Share Capital | 33 | 33 | 33 |
| Reserves & Surplus | -249 | 93 | 480 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 |
|---|---|---|---|
| Operating Activities | -360 | -429 | -69 |
| Investing Activities | 158 | 392 | -548 |
| Financing Activities | 199 | 42 | 617 |
| Net Cash Flow | -3 | 5 | -1 |